Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
The Faces of Luminex: Jimm Chengary, Global Product Management
The area of bloodstream infection is a key focus for Luminex. Our VERIGENE® platform helps clinical lab teams to rapidly diagnose sepsis, track antibiotic resistance markers, and assist physicians in getting patients on the most appropriate therapy sooner. Overseeing this area is Jimm Chengary, who joined Luminex earlier this year and is based in our Chicago office. The DePaul University graduate holds a bachelor’s degree in finance and accounting as well as an MBA in marketing and finance.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.